|
CCRN4L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.73289999999749E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80912999999672E-05 |
| Normal-vs-Stage2 |
7.753100E-04 |
| Normal-vs-Stage3 |
7.124000E-03 |
| Normal-vs-Stage4 |
2.017200E-01 |
| Stage1-vs-Stage2 |
1.788990E-01 |
| Stage1-vs-Stage3 |
4.796400E-02 |
| Stage1-vs-Stage4 |
1.004650E-01 |
| Stage2-vs-Stage3 |
5.027600E-01 |
| Stage2-vs-Stage4 |
2.857600E-01 |
| Stage3-vs-Stage4 |
4.853200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63970000000213E-05 |
| Normal-vs-AfricanAmerican |
7.55410000000678E-05 |
| Normal-vs-Asian |
7.960400E-02 |
| Caucasian-vs-AfricanAmerican |
5.379800E-01 |
| Caucasian-vs-Asian |
4.729200E-01 |
| AfricanAmerican-vs-Asian |
6.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76825000000047E-05 |
| Normal-vs-Female |
5.836200E-04 |
| Male-vs-Female |
7.996600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.90160000000228E-05 |
| Normal-vs-Extreme_Weight |
1.7296E-05 |
| Normal-vs-Obese |
2.224400E-04 |
| Normal-vs-Extreme_Obese |
4.624400E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.685200E-01 |
| Normal_Weight-vs-Obese |
4.396400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.602200E-01 |
| Extreme_Weight-vs-Obese |
6.629600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.565180E-01 |
| Obese-vs-Extreme_Obese |
9.341400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.159160E-01 |
| Normal-vs-Age(41-60Yrs) |
5.93260000000262E-05 |
| Normal-vs-Age(61-80Yrs) |
1.8109599999927E-05 |
| Normal-vs-Age(81-100Yrs) |
2.89980000001133E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.080000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.255360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.202300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.358400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.688490E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.807770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.44549999997668E-06 |
| Normal-VS-Type2 PRCC |
1.389310E-04 |
| Normal-VS-KIRP CIMP |
7.182000E-01 |
| Normal-VS-Unclassified PRCC |
5.61940000000094E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.26500000000729E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.318000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.617890E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.949700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.286600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.825600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164510E-04 |
| Normal-vs-N1 |
4.201900E-02 |
| Normal-vs-N2 |
9.610000E-01 |
| N0-vs-N1 |
1.399970E-01 |
| N0-vs-N2 |
3.038800E-01 |
| N1-vs-N2 |
3.126400E-01 |
|
|
